RA Capital Launches Fourth SPAC as Private Investment Pipeline Continues to Grow

The life sciences firm has deployed more than $5 billion into private companies since 2020, giving it a broad universe of connections to potential health care acquisition targets.

Stephen Taub July 16, 2026

RA Capital Management has launched its fourth special purpose acquisition company, extending a strategy that reflects the firm's growing presence in private health care investing. The firm has invested more than $5 billion in private companies since 2020 and backed hundreds of biotech and health

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.25.00 build:2026-07-06 Login